3 Hot Reads From TheStreet's Top Premium Columnists
Jim Cramer and our other experts discuss the FAANG stocks, a market bottom, and potential biotech targets.
We Got Too Negative: Cramer's 'Mad Money' Recap
Jim Cramer says we're seeing powerful reminders that there's a better time to sell than in the teeth of a decline. Investors must use discipline to their advantage.
Markets Keep Eye on China Presidential Speech; Biotechs Bounce -- ICYMI
Here's what you need to know for Monday, April 9.
Dow Rises Sharply on Softer U.S. Approach in China Trade War; Tech Soars
Stocks rise Monday following tweets from Donald Trump that appeared to indicate the U.S. was softening its approach in its trade battle with China.
Video: Jim Cramer Reacts to Novartis' Acquisition of AveXis
Novartis agreed to acquire AveXis for $8.7 billion on Monday. TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer reacts.
Cisco Systems Stock Leaps On Q4 Earnings Beat, 2023 Sales Outlook As Supply Chain Pressures Ease
"Overall supply constraints began to ease slightly at the back half of the fourth quarter and continuing into the start of the first quarter," said CEO Chuck Robbins.
Apple Preparing For iPhone 14 Launch On September 7 - Report
Bloomberg reported late Wednesday that Apple is eyeing a September 7 launch date for its new iPhone 14 series.
Huge Las Vegas Strip Casino Project Moves Forward
Sin City looks set to welcome another massive resort/casino that's going to compete with industry leaders Caesars and MGM.
Kohl's Stock Slumps After Retailer Guts Full-Year Profit Forecast As Shoppers Feel Inflation Squeeze
“Second quarter results were impacted by a weakening macro environment, high inflation and dampened consumer spending, which especially pressured our middle-income customers," said CEO Michelle Gass.